Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 26, 2018 - The FDA announced the discontinuation of Eisai's Hexalen (altretamine) capsules.
Download PDF
Return to publications
